Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Acting Risperidone in First-Episode Schizophrenia
NCT00220714Phase 4Unknown
- Sponsor
- SUNY Downstate Health Sciences University
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in schizophrenia, schizophreniform disorder, schizoaffective disorder, sponsored by SUNY Downstate Health Sciences University. Status: unknown.
02
Drugs
risperidone
03
Conditions
schizophreniaschizophreniform disorderschizoaffective disorder
Beyond the preview
Go deeper on NCT00220714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00220714.